FDA Inspection 601426 - AstraZeneca Pharmaceuticals LP - June 16, 2009

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on June 16, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: AstraZeneca Pharmaceuticals LP
Inspection Date: June 16, 2009
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · bc5d904d-a3aa-4c0c-8f66-ceb8716194cb

Violation Codes5

21 CFR 211.100(b)21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 600.14(a)(1)21 CFR 600.14(c)

Full citation text and observation details available on the Dashboard.